Skip to content

Our Pipeline

Our Breakthroughs in science and technology
aim to turn once-futuristic ideas into reality through the development of bioengineered regenerative human tissues. Pioneering research in three revolutionary platforms – Acellular Tissue Engineered Vessels, Advanced Organ Systems, and Advanced Tissue Constructs – we are investigating regenerative approaches for a wide range of clinical needs.

Some information below relates to investigational products and/or uses for which safety and efficacy have not been established. There is no guarantee that pipeline products or investigational uses will receive approval from health authorities.
Preclinical
Phase 2
Phase 3

Acellular Tissue Engineered Vessels

vascular trauma repair
FDA APPROVED
Dialysis (AV Access)
PERIPHERAL ARTERY DISEASE (PAD)
CORONARY ARTERY BYPASS GRAFTING (CABG)
Pediatric Heart Disease

Advanced Organ Systems

Biovascular pancreas™ (Type 1 diabetes)
Lung

Advanced Tissue Constructs

Urinary Conduit
Tracheal replacement
Esophageal Replacement
Last updated December, 2024
Acellular Tissue Engineered Vessels Advanced Organ Systems Advanced Tissue Constructs

You are now leaving humacyte.com.

You are now leaving humacyte.com. This link leads to symvess.com, which is intended for United States residents only. By clicking this link you verify that you are a United States resident.